Your browser doesn't support javascript.
loading
Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans.
Sommer, Christine; Vangberg, Kjersti G; Moen, Gunn-Helen; Evans, David M; Lee-Ødegård, Sindre; Blom-Høgestøl, Ingvild K; Sletner, Line; Jenum, Anne K; Drevon, Christian A; Gulseth, Hanne L; Birkeland, Kåre I.
Afiliación
  • Sommer C; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, 0424 Oslo, Norway.
  • Vangberg KG; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, 0424 Oslo, Norway.
  • Moen GH; Department of Nutrition, Institute of Basic Medical Sciences, Faculty Medicine, University of Oslo, 0317 Oslo, Norway.
  • Evans DM; Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.
  • Lee-Ødegård S; Institute for Molecular Bioscience, The University of Queensland, St Lucia QLD 4072, Australia.
  • Blom-Høgestøl IK; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba QLD 4102, Australia.
  • Sletner L; Population Health Science, Bristol Medical School, University of Bristol, BS8 1QU Bristol, UK.
  • Jenum AK; Department of Public Health and Nursing, K.G. Jebsen Center for Genetic Epidemiology, NTNU, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
  • Drevon CA; Institute for Molecular Bioscience, The University of Queensland, St Lucia QLD 4072, Australia.
  • Gulseth HL; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba QLD 4102, Australia.
  • Birkeland KI; MRC Integrative Epidemiology Unit, University of Bristol, BS8 2BN Bristol, UK.
J Clin Endocrinol Metab ; 108(5): 1110-1119, 2023 04 13.
Article en En | MEDLINE | ID: mdl-36459457

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Endocrinol Metab Año: 2023 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Endocrinol Metab Año: 2023 Tipo del documento: Article País de afiliación: Noruega